The 20 Best Renal Oncocytoma Doctors in New York, US

Eric Kauffman is a Urologist in Buffalo, New York. Dr. Kauffman is rated as an Elite provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Oncocytoma, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Nephrectomy, and Prostatectomy.

Ian Ganly is a General Surgeon in New York, New York. Dr. Ganly is rated as an Elite provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Laryngectomy. Dr. Ganly is currently accepting new patients.

Ronald Kaufman is a Urologist in Albany, New York. Dr. Kaufman is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Enlarged Prostate (BPH), Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Aquablation, and Nephrectomy.

. Dr. Ferrara is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Mikulicz Disease, Male Pattern Baldness, Salivary Duct Stones, and Mouth Sores.

Thomas Schwaab is a Urologist in Buffalo, New York. Dr. Schwaab is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Renal Oncocytoma, Nephrectomy, and Reconstructive Urology Surgery.

Joph Steckel is a Urologist in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Sanford Dubner is an Otolaryngologist in Lake Success, New York. Dr. Dubner is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Thyroid Nodule, Mikulicz Disease, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Thymectomy.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy.

Kenneth Hu is a Radiation Oncologist in New York, New York. Dr. Hu is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Tongue Cancer, and Teratocarcinosarcoma.

William Huang is a Urologist in New York, New York. Dr. Huang is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Nephrectomy, and Cystectomy.

Jonah Marshall is a Urologist in Albany, New York. Dr. Marshall has been practicing medicine for over 22 years and is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Ureteroscopy. Dr. Marshall is currently accepting new patients.

Dennis Rassias is a General Surgeon and a Thoracic Surgeon in Albany, New York. Dr. Rassias has been practicing medicine for over 28 years and is rated as an Experienced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Hiatal Hernia, Pleuropulmonary Blastoma, Lung Cancer, Gastrostomy, and Gastrectomy. Dr. Rassias is currently accepting new patients.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as a Distinguished provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications. Dr. Kavoussi is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Tissue Biopsy, and Thyroidectomy.

Dev Kamdar is an Otolaryngologist in New Hyde Park, New York. Dr. Kamdar is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy.

"Brett Miles, DDS, MD, is vice president of otolaryngology for Northwell facilities in New York City boroughs and Westchester County. He is also the chair of otolaryngology and head and neck surgery at Lenox Hill Hospital and Manhattan Ear, Eye Throat Hospital, and the surgical lead of the head and neck disease management team in the Northwell Health Cancer Institute.Dr. Miles manages head and neck tumors, including those of the mouth and throat, with state-of-the-art surgical techniques including microvascular reconstruction. His clinical interests include computerized reconstruction, minimally invasive robotic surgery and HPV-related head and neck cancer.""Head and neck cancer can be challenging to treat, but highly meaningful,"" Dr. Miles says. ""The relationships I form with my patients are a source of personal motivation. Seeing them move forward with their lives after treatment is inspiring.""Dr. Miles earned a medical degree from University of Texas Southwestern Medical School and a doctorate of dental surgery from Creighton University. He completed residencies in Oral and Maxillofacial surgery and Otolaryngology-Head and Neck surgery at the University of Texas Southwestern Medical Center. He received fellowship training in head and neck oncology at the University of Toronto and is board-certified by both the American Board of Oral and Maxillofacial Surgery and the American Board of Otolaryngology - Head Neck Surgery.Dr. Miles works collaboratively with a team of experts to offer the highest quality cancer care and access to clinical trials. They include imaging specialists, radiation oncologists, medical oncologists, nurse practitioners, and speech and swallowing therapists.Dr. Miles is a Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He has published 170 articles in peer-reviewed journals and often lectures at national and international conferences. He is on the council of the International Association of Oral Oncology, and the American Head and Neck Society's Reconstructive Head and Neck Research Board. He has been a New York Magazine and a New York Metro Area Top Doctor for the last several years.Overall, compassion and empathy are integral to his job. ""Undergoing cancer surgery is a very stressful time for patients and families,"" Dr. Miles says. ""My focus is on cancer and the people affected by cancer.""". Dr. Miles is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Human Papillomavirus Infection, Adenoid Cystic Carcinoma, Salivary Gland Tumors, Laryngectomy, and Gastrostomy.

Nicholas Karanikolas is an Oncologist and a Urologist in Staten Island, New York. Dr. Karanikolas is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Ureteroscopy, and Prostatectomy.

I strive to provide the best and most current techniques in head and neck surgery. Following my training at the University of Toronto, Cedars Sinai in Los Angeles and Sloan Kettering here in NY, I was appointed as Residency Director at Manhattan Eye Ear Throat Hospital. Since 1987, I have been in private practice in Manhattan and Queens, where I am the Chief of the Head and Neck Service. I have had over 30 years of experience dealing with tumors in this region.My interests include thyroid and parathyroid surgery, salivary gland surgery, cancers of the oral cavity and larynx and the treatment of sinusitis. Nerve monitoring during complex surgery is frequently utilized.This is a solo practice so all patients are seen and treated by myself, both in the office and in the operating room. Dr. Shemen is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. His top areas of expertise are Nonsyndromic Hearing Loss, Deafness Hypogonadism Syndrome, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Painful Swallowing, and Thyroidectomy.

Dr. Meyer is a fellowship-trained minimally invasive urologic surgeon. Having trained with world-renowned experts and pioneers of laparoscopic and robotic surgery, her clinical practice focuses on the diagnosis and treatment of prostate cancer and kidney cancer. Dr. Meyer's clinical interests and surgical expertise also include the treatment of enlarged prostate (BPH), kidney stones, ureteropelvic junction obstruction, and urothelial cancers of the kidney and ureter.Dr. Meyer graduated Phi Beta Kappa and Summa Cum Laude from Columbia University. She received her medical degree from Columbia University College of Physicians and Surgeons where she was elected to the prestigious Alpha Omega Alpha Society. She completed her internship in General Surgery and residency in Urology at the James Buchanan Brady Urological Institute at Johns Hopkins. She then completed a fellowship in minimally invasive urologic surgery at The Smith Institute for Urology at Northwell Health. She is currently the Director of Robotic Education and Associate Program Director at The Smith Institute for Urology at Lenox Hill. Dr. Meyer is rated as an Advanced provider by MediFind in the treatment of Renal Oncocytoma. Her top areas of expertise are Renal Oncocytoma, Prostate Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Prostatectomy.